Lung Cancer Surgery Market worth 29.99 Billion USD by 2021

2. MarketsandMarkets Presents Lung Cancer Surgery Market Insights on Scope and Growing Demands 2021 https://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html

3. ➢ [135 Pages Report] The lung cancer surgery market is projected to reach USD 29.99 billion by 2021 from USD 21.58 billion in 2016, at a CAGR of 6.8% from 2016 to 2021. Increasing prevalence of lung cancer, rising ageing population, rising awareness about advanced treatment methods are the major driving factors for this market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021. ➢ This market is segmented based on device, procedure, and region. On the basis of device, the market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment. In 2016, the surgical instrument segment is expected to account for the largest share of the market due to increasing prevalence of lung cancer and growing aging population. ➢ On the basis of procedure, the market is classified into thoracotomy and minimally invasive surgeries. The thoracotomy segment further sub segmented into lobectomy, sleeve resection, segmentectomy, and pneumonectomy. In 2016, the thoracotomy segment is expected to account for the largest share of the market. This large share can be attributed to increasing technological advancements in lung cancer treatment. https://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html

4. Early buyers will receive 10% customization on Reports. https://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html

5. ➢ The global market is segmented into four major regions—North America, Europe, Asia, and Rest of the World. In 2016, North America is expected to account for the largest share of the market, followed by Europe. North America will continue to dominate the market in the forecast period due to availability of reimbursement for lung cancer surgeries and increasing prevalence of lung cancer in the region. However, the market in Asia is expected to witness the highest CAGR, with the growth centered on China, Japan, and India. ➢ Thoracotomy is the process of making incisions in the chest wall to gain access to the thoracic organs, such as the heart, lungs, and anterior spine. In lung cancer treatment, surgeons perform thoracotomy procedures in order to remove cancerous tissues from lungs. These surgeries are widely adopted to confirm the diagnosis of lung cancer, remove tumors and scar tissue, or fix air leaks in the lung. Lobectomy, segmentectomy, sleeve resection, and pneumonectomy are the different types of thoracotomy procedures carried out by surgeons to treat patients suffering from lung cancer https://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html

6. ➢ Minimally conventional open surgeries. Video-assisted thoracoscopic surgery (VATS) and robotic surgeries are examples of minimally invasive surgeries. These surgeries are especially carried out to perform lobectomy or segmentectomy procedures for treating lung cancer patients. VATS is a surgical method used for the diagnosis and treatment of lung diseases, especially non-small-cell lung carcinoma. Despite the growing acceptance for VATS resections, this minimally invasive technique has had slow adoption due to concerns regarding oncological principles, costs, possible complications, time spent on learning, and lack of trained expertise for the same. Shorter hospital stays, smaller incisions, and faster recovery are the major driving factors for minimally invasive surgeries. These advantages of minimally invasive surgeries are expected to fuel the market during the forecast period. ➢ Key players in the lung cancer surgery market include Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany). ➢ To speak to our analyst for a discussion on the above findings, click Speak to Analyst https://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html invasive surgeries are more advanced surgical methods than

7. About MarketsandMarkets MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. https://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html

8. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/ Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets https://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html